J Cassidy

6.5k citations
72 papers · 4.5k · 3 hit papers · h-index 33

Impact in

  • Hematology top 1%
    • Autoimmune and Inflammatory Disorders Research
  • Oncology top 2%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology

Papers in

    • Colorectal Cancer Treatments and Studies 22
    • Cancer Treatment and Pharmacology 17
    • Colorectal Cancer Surgical Treatments 5
    • Cancer therapeutics and mechanisms 8
    • Biochemical and Molecular Research 5

J Cassidy

71 papers receiving 4.3k citations

J Cassidy's Hit Papers

Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties 2011 · 360 citations
3600+16+32Years since publication100200300400500

Peers

J Cassidy
Comparison fields: 5 of 126
  • Hematology 716
  • Oncology 1.4k
  • Biomaterials 535
  • Rheumatology 389
  • Speech and Hearing 161
Replace Curt Peterson with:
Curt Peterson Sweden
Brigitte C. Widemann United States
Zhengjia Chen United States
Bonnie S. Glisson United States
Irwin H. Krakoff United States
Mark L. Bernstein United States
Peter M. Anderson United States
Carla M.L. van Herpen Netherlands
Ann T. Farrell United States
Eric Winquist Canada
J Cassidy relative to Curt Peterson Sweden Curt Peterson's profile →
Citations per field
00.5×6.5×
Curt Peterson · 1×
Citations per year

Countries citing papers authored by J Cassidy

Since Specialization
Citations

This map shows the geographic impact of J Cassidy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Cassidy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Cassidy more than expected).

Fields of papers citing papers by J Cassidy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Cassidy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Cassidy. The network helps show where J Cassidy may publish in the future.

Co-authors

The 25 scholars most cited alongside J Cassidy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with J Cassidy Line = papers co-authored together J Cassidy links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.
Hit paper breakdown →
1999574
2
Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation.
Hit paper breakdown →
1977551
3
Disulfiram modulated ROS–MAPK and NFκB pathways and targeted breast cancer cells with cancer stem cell-like properties
Hit paper breakdown →
2011360
4 1986333
5 2006221
6 2011180
7 1992126
8 2011122
9 2009122
10 2005110
11 1999107
12 1996103
13 201193
14 200492
15 199890
16 200288
17
A phase I and pharmacokinetic study of LY231514, the multitargeted antifolate.
199878
18
Regulation of dihydropyrimidine dehydrogenase in colorectal cancer.
199976
19 199875
20 199969

About J Cassidy

J Cassidy is a scholar working on Oncology, Molecular Biology, Pathology and Forensic Medicine, Immunology and Pulmonary and Respiratory Medicine, having authored 72 papers that have together received 4.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (22 papers), Cancer Treatment and Pharmacology (17 papers), Cancer therapeutics and mechanisms (8 papers), Immunodeficiency and Autoimmune Disorders (6 papers), Colorectal Cancer Surgical Treatments (5 papers), Biochemical and Molecular Research (5 papers), Nanoparticle-Based Drug Delivery (5 papers) and Ovarian cancer diagnosis and treatment (4 papers). The work is most often cited by research in Hematology (716 citations), Oncology (1.4k citations), Biomaterials (535 citations), Rheumatology (389 citations) and Speech and Hearing (161 citations). J Cassidy has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Chris Twelves, Juan Bass, Jane G. Schaller, Virgil Hanson, John Baum, Joseph E. Levinson, Earl J. Brewer, Stan B. Kaye, Daniela Fraier and Weiguang Wang. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology and Academic Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact